A Retrospective Study of Extended Spectrum Beta-Lactamases (ESBL) Urinary Tract Infections Treated with Fosfomycin and in vitro Susceptibility of 102 Isolates to Fosfomycin

References (19)

1. 1 International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases [DOI]
2. 2 Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs [DOI]
3. 3 Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) [DOI]
4. 4 Fosfomycin: an old, new friend? [DOI]
5. 5 Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms [DOI]
6. 6 Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates [DOI]
7. 7 Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin [DOI]
8. 8 Fosfomycin Trometamol: A Review of Its Use as a Single-Dose Oral Treatment for Patients with Acute Lower Urinary Tract Infections and Pregnant Women with Asymptomatic Bacteriuria [DOI]
9. 9 Susceptibility of Urinary Tract Bacteria to Fosfomycin [DOI]
10. 10 Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates [DOI]
11. 11 Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer? [DOI]
12. 12 Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin [DOI]
13. 13 Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance [DOI]
14. 14 Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods [DOI]
15. 15 Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Coresistance Phenotype among Recent Escherichia coli Isolates from U.S. Veterans [DOI]
16. 16 Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium: Potential Utility of Fosfomycin [DOI]
17. 17 [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
18. 18 Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial [DOI]
19. 19 Antibacterial Activity of Fosfomycin against Uropathogens [DOI]

Cited by 0

No indexed citations yet.

Related research

• Profile of Drug Resistant Gram Negative Bacteria from ICU at a Tertiary Care Center of India — shares topic coverage
• Characterization of the Genetic Supports for Betalactam Resistance in Escherichia coli Strains of Porcine Origin Producing Extended-spectrum Beta-Lactamase (ESBL) — shares topic coverage
• Evaluation of the NDP Test, a Novel Chromogenic Test for Rapid Detection of Extended Spectrum β-Lactamase Producing Enterobacteriaceae — shares topic coverage
• Detection of Hypervirulent Klebsiella pneumoniae in Tanta University Hospital, Egypt — shares topic coverage
• Antibiotic Susceptibility Test of Klebsiella pneumoniae and K. oxytoca Isolated from Different Clinical Samples and Perform Random Amplified Polymorphic DNA among K. pneumoniae — shares topic coverage